Odin Biotech Partners Overview
- Founded
- 2014
- Status
- Private
- Latest Deal Type
- Series A
- Latest Deal Amount
- $2.2M
- Investors
- 2
Odin Biotech Partners General Information
Description
Developer of drugs for diseases of the retina. The company develops novel therapeutics for debilitating ophthalmic diseases which can be used for the treatment of wet age-related macular degeneration.
Contact Information
Website
Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Drug Discovery
Other Industries
Other Pharmaceuticals and Biotechnology
Primary Office
- 4441 Buena Vista Street
- Dallas, TX 75205
- United States
+1 (469) 000-0000
Odin Biotech Partners Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Angel (individual) | 28-Aug-2014 | $2.2M | 00.00 | Completed | Startup | |
| 1. Accelerator/Incubator | Completed | Startup |
Odin Biotech Partners Executive Team (1)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Karl Csaky Ph.D | Founder, Chief Medical Officer, Chief Executive Officer & Board Member |
Odin Biotech Partners Board Members (2)
| Name | Representing | Role | Since |
|---|---|---|---|
| Karl Csaky Ph.D | Odin Biotech Partners | Founder, Chief Medical Officer, Chief Executive Officer & Board Member | 000 0000 |
| Melissa Krauth | 2M Companies | Interim Chief Executive Officer & Board Member | 000 0000 |
Odin Biotech Partners Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| Claria Bioscience | Other | Minority | 000 0000 | 000000 0 | |
| 2M Companies | Family Office | Minority | 000 0000 | 000000 0 |